Curia

Meet Dr. VijayaSaradhi Sivalenka and get a behind-the-scenes look at our cutting-edge capabilities—from complex synthetic organic and medicinal chemistry to sustainable innovations like photo-redox and Green Chemistry. With deep expertise in oncology, ALS, pain, and anxiety programs, our Hyderabad team has earned lasting partnerships and recognition in patents and high-impact journals. Get a closer look at how Curia Hyderabad accelerates cutting-edge Discovery Chemistry — from first idea to optimized lead. Learn more here: https://hubs.li/Q03zNm1p0 #MedicinalChemistry #CDMO #GreenChemistry

Join Teresa Pallotta, Vice President and Head of Small Molecule Sales at Curia, as she joins the panel at Endpoints News, Manufacturing Day on August 6 at 10 AM ET to discuss “Battling Wildfires in Pharma Supply Chains: CDMO Leaders Weigh In.” In this discussion, CDMO leaders will explore: 🔹 Rethinking global supply chain strategies 🔹 How better partnerships can drive cost-efficiency and access 🔹 Flexible, resilient and bespoke manufacturing for complex pipelines Don’t miss this timely conversation on the future of pharmaceutical manufacturing. Register here: https://hubs.li/Q03zx0700

The Baculovirus Expression Vector System (BEVS) is an established method within the scientific and industrial communities for generating large quantities of recombinant protein. Did you know Curia’s team in Hopkinton, MA has 25+ years of experience working on baculovirus programs? Learn more at: https://hubs.ly/Q03zw-cM0 #Baculovirus #Biologics #CDMO

Did you know? Flow technology is rapidly transforming API manufacturing. With enhanced quality, yield and process safety, the integration of continuous flow process decreases cost and timelines. In our latest white paper, Curia experts Dr. Tummanapalli Satyanarayana (Ph.D., MBA-WX) and Dr. Muralikrishna Valluri outline the benefits of flow chemistry, key strategies for successful implementation, and real-world examples of reactions adapted to flow at commercial scale. 👉 Read here: https://hubs.li/Q03zjpr20 #FlowChemistry #SmallMolecule #CDMO

Looking for a CDMO for your highly viscous product? Curia’s Burlington, MA site, located just outside of Boston, can aseptically formulate and fill products with viscosities up to 10,000+ cP. Our Burlington, MA site also has: • Clinical and commercial capacity on the pre-filled syringe line • Capabilities to fill 1mL to 10ml syringes, including 1 ml long • A DEA registration for Schedule II – V controlled substances, in addition to being an FDA approved facility Learn more at: https://hubs.li/Q03z3YnL0 #CDMO #DrugProduct #ViscousFormulation #DrugDevelopment

We’re proud to share that Dr. Vinothkumar Vinayagam , Senior Research Scientist III at Curia, and his team have had their research published in the European Journal of Organic Chemistry: “Green Approach for Copper-Free Pd-Catalyzed Sonogashira Cross-Coupling Using Saponin-Based Micellar Catalysis in Water at Ambient Temperature.” This innovation reduces EHS risks and offers a safer, more sustainable approach to chemical synthesis—advancing our commitment to green chemistry. In the pharmaceutical industry, over 80% of organic waste comes from solvents. Dr. Kumar and his team identified Saponin, an inexpensive, biodegradable, and natural surfactant that effectively forms a micellar-catalysis system in water. This system enables a challenging C(sp2)─C(sp) coupling with a broad range of aryl/heteroaryl halides and diverse terminal alkynes at room temperature. We believe Saponin can serve as a cost-effective, long-term sustainable alternative to designer surfactants. Read the full publication here: https://hubs.li/Q03yKDkf0 #GreenChemistry #ESG #OrganicChemistry #SustainableSolutions #EnvironmentalHealth #CDMO

Yesterday Scott A., Director, Process Development at Curia presented “Guide To Lean Manufacturing: Redefining The Concept of mRNA Development” at the 5th Annual mRNA-Based Therapeutics Summit. Learn more about Curia’s end-to-end capabilities for mRNA projects, including manufacturing of mRNA drug substance and LNP formulation and fill/finish at: https://hubs.li/Q03yv3920 Want to meet with Curia’s RNA and LNP experts? Reach out to us at: https://lnkd.in/evDfi5UM #CDMO #mRNADevelopment

What does it mean to bring science to life? For us, it starts with #curiosity — and it turns into action through deep expertise, global collaboration, and a shared purpose that connects every person across our 20+ sites. We support discovery. We power development. We manufacture with care and precision. But more than that—we show up every day to help turn ideas into impact. From independent biotechs to global pharma, from early R&D to commercial scale, we meet our partners wherever they are—and move with them every step of the way. We’re proud to support programs that change lives and collaborate with government agencies advancing public health on a broader scale. What we offer isn’t just a set of services—it’s an integrated experience shaped by science, strengthened by people and driven by purpose. This is more than what we do. This is who we are. Explore our full capabilities: https://hubs.li/Q03xG98d0

At our Springfield, Missouri site, we specialize in something critical—manufacturing controlled active pharmaceutical substances, from Schedule I through V. Using advanced chemical synthesis, our team supports projects from lab scale all the way to several metric tons. It’s precise, compliant and high-stakes work, and we’re proud to do it right here in Springfield. It’s just one of the many ways we support pharmaceutical innovation across the U.S. and beyond. Learn more here: Learn more: https://hubs.li/Q03xsFMB0 #CuriaCDMO #APIManufacturing #HighlyPotentAPIs #CDMO